论文部分内容阅读
目的:观察蒙西医结合治疗慢性心力衰竭的疗效及安全性。方法:选择60例慢性心力衰竭患者,随机分为治疗组和对照组各30例,对照组患者给予强心剂地高辛片、利尿速尿片、血管扩张剂卡托普利等常规治疗,治疗组患者在此基础上辨证加用蒙药复方制剂。两组患者疗程均为4周。结果:经过治疗,两组患者的心衰症状积分、心功能分级等指标较治疗前均有所改善,差异具有统计学意义(P<0.05);且治疗组与对照组相比,改善更为显著,差异具有统计学意义(P<0.05)。结论:对慢性心力衰竭患者在常规西药治疗的基础上加用蒙药复方制剂,可改善临床症状和心功能以及心脏超声EF指标,提高临床疗效,值得临床推广应用。
Objective: To observe the efficacy and safety of Mongolian medicine in treating chronic heart failure. Methods: Sixty patients with chronic heart failure were randomly divided into treatment group (n = 30) and control group (n = 30). Patients in the control group were given routine drugs such as digoxin tablets, diuresis diapers and captopril vasodilators. On this basis, patients with syndrome differentiation plus Mongolian compound preparation. Two groups of patients were treated for 4 weeks. Results: After treatment, the scores of heart failure symptom scores and heart function grading in both groups were improved compared with those before treatment, the difference was statistically significant (P <0.05); and compared with the control group, the treatment group improved more Significantly, the difference was statistically significant (P <0.05). Conclusion: It is worthy of clinical application to improve the clinical symptoms, heart function and echocardiographic EF indexes of patients with chronic heart failure by adding Mongolian compound prescriptions on the basis of conventional western medicine.